Lighthouse Pharmaceuticals
Latest round
- Series A
Last raised
- Apr 2026
Total raised
- $12M
Investors
- 2
About Lighthouse Pharmaceuticals
Lighthouse Pharmaceuticals specializes in therapeutics targeting neurodegenerative conditions. The company is headquartered in Novato, US.Lighthouse Pharmaceuticals focuses on developing innovative therapeutics targeting significant unmet medical needs, primarily in the realm of neurodegenerative diseases such as Alzheimer’s disease. Its flagship product, LHP588, is a next-generation gingipain inhibitor designed for patients with P. gingivalis-positive mild to moderate Alzheimer’s disease, addressing neuroinflammation and cognitive decline linked to periodontal pathogens. The company is focused on launching new products targeting neurodegenerative diseases and aims to expand into additional geographical markets, although specific regions are not detailed.
Who invested in Lighthouse Pharmaceuticals
2 investors across 1 round
See all investors in Lighthouse Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 28, 2026
Amount
$12M
Investors
Questions about Lighthouse Pharmaceuticals
Who invested in Lighthouse Pharmaceuticals?
Lighthouse Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lighthouse Pharmaceuticals raised?
Lighthouse Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Lighthouse Pharmaceuticals last raise money?
Lighthouse Pharmaceuticals's most recent round on record is a Series A, in Apr 2026.
What does Lighthouse Pharmaceuticals do?
Lighthouse Pharmaceuticals specializes in therapeutics targeting neurodegenerative conditions.
Where is Lighthouse Pharmaceuticals headquartered?
Lighthouse Pharmaceuticals is headquartered in Novato, US.
Which VCs invest in companies like Lighthouse Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lighthouse Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Lighthouse Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.